Venue: ICM Congress Centre, Munich, DE
Website: go to
While providing the usual high-quality educational and scientific sessions on all areas of interventional radiology, CIRSE 2020 will focus particularly on evidence-based practice, with various Hot Topic Symposia, Expert Round Tables, and Focus Sessions examining what we have learned for our daily practice from the relevant registries and studies.
As part of the dedicated oncology track, a Hot Topic Symposium will examine the preliminary results from CIRSE’s observational studies, including the first data release from the CIRT registry on SIR-Spheres therapy, which has reached the 1,000-patient benchmark, and an interim analysis of the CIREL registry on LifePearl Microspheres. A Clinical Evaluation Course will delve into the evidence on all currently available treatments for metachronous CRC liver oligo-metastatic disease, from surgical options to percutaneous ablation, transarterial chemoembolisation, and transarterial chemotherapies all the way to chemoembolisation, providing the audience with a balanced picture of the current evidence on all treatment modalities.
As part of the venous topic track, an expert panel will discuss evidence-based practice in hemodialysis management, casting a look at the new K-DOQI guidelines and giving attendees an overview of randomized controlled trials for drug-eluting technologies and those examining covered stents.
Within the arterial track, a Clinical Evaluation Course will examine the preliminary results from the relevant randomized controlled trials on carotid treatment.
The Interdisciplinary Endovascular Aortic Symposium, our “congress within the congress” will again be prominently featured within the program, covering all aspects of the aortic intervention.
Following its successful introduction at last year’s congress, CIRSE 2020 will also feature another PAD Day to examine all aspects of PAD treatment. As part of this micro-track, the First@CIRSE session will again provide a platform for the release of the latest evidence from trials and studies on peripheral arterial disease.
CIRSE is carefully monitoring the environment surrounding the COVID-19 pandemic and is preparing for all contingencies. CIRSE remains committed to delivering an exceptional event and is currently moving forward with preparations for the CIRSE 2020 Annual Congress to take place as planned.
Depending on the further development of the COVID-19 crisis, CIRSE will make thoughtful and informed decisions and will provide updates as soon as available.
For Undergraduate European Medical Student: FREE